Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial

Hum Gene Ther. 2003 Sep 20;14(14):1347-60. doi: 10.1089/104303403322319426.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • Adolescent
  • Adult
  • Antigens, CD34 / metabolism
  • Cancer Vaccines / immunology*
  • Clinical Protocols
  • Dendritic Cells / immunology*
  • Female
  • Gene Transfer Techniques
  • Genetic Vectors*
  • Humans
  • Immunization
  • Male
  • Melanoma / immunology*
  • Monophenol Monooxygenase / genetics*
  • Transduction, Genetic
  • Vaccinia virus / immunology

Substances

  • Antigens, CD34
  • Cancer Vaccines
  • Monophenol Monooxygenase